Search by Drug Name or NDC
NDC 68180-0760-01 Amlodipine Besylate and Benazepril Hydrochloride 10; 40 mg/1; mg/1 Details
Amlodipine Besylate and Benazepril Hydrochloride 10; 40 mg/1; mg/1
Amlodipine Besylate and Benazepril Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE.
Product Information
NDC | 68180-0760 |
---|---|
Product ID | 68180-760_3f88556b-447a-40c5-917a-e50e0d818c5a |
Associated GPIs | 36991502200160 |
GCN Sequence Number | 060723 |
GCN Sequence Number Description | amlodipine besylate/benazepril CAPSULE 10 MG-40MG ORAL |
HIC3 | A4K |
HIC3 Description | ACE INHIBITOR-CALCIUM CHANNEL BLOCKER COMBINATION |
GCN | 26950 |
HICL Sequence Number | 010041 |
HICL Sequence Number Description | AMLODIPINE BESYLATE/BENAZEPRIL HCL |
Brand/Generic | Generic |
Proprietary Name | Amlodipine Besylate and Benazepril Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Amlodipine Besylate and Benazepril Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 10; 40 |
Active Ingredient Units | mg/1; mg/1 |
Substance Name | AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE |
Labeler Name | Lupin Pharmaceuticals, Inc. |
Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Ch |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA078466 |
Listing Certified Through | 2024-12-31 |
Package
NDC 68180-0760-01 (68180076001)
NDC Package Code | 68180-760-01 |
---|---|
Billing NDC | 68180076001 |
Package | 100 CAPSULE in 1 BOTTLE (68180-760-01) |
Marketing Start Date | 2011-07-05 |
NDC Exclude Flag | N |
Pricing Information | N/A |